Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450806

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450806

Point of Care Fentanyl Test Kits Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7600
PDF (Corporate User License)
USD 10600

Add to Cart

Persistence Market Research has recently conducted a comprehensive analysis of the global Point of Care Fentanyl Test Kits Market, providing valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. This report presents exclusive data and statistics forecasting the market's growth trajectory from 2023 to 2030.

The global point of care fentanyl test kits market is forecast to expand at a CAGR of 6.0% and thereby increase from a value of US$99 Mn in 2023, to US$148.9 Mn by the end of 2030.

Key Insights:

  • Point of Care Fentanyl Test Kits Market Size (2023E): US$99.0 Mn
  • Projected Market Value (2030F): US$148.9 Mn
  • Global Market Growth Rate (CAGR 2023 to 2030): 6.0%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 5.0%

Point of Care Fentanyl Test Kits Market - Report Scope:

The Point of Care Fentanyl Test Kits Market comprises diagnostic tools utilized for rapid and accurate detection of fentanyl in various settings, including emergency departments, drug rehabilitation centers, law enforcement agencies, and workplace drug testing programs. These test kits play a crucial role in combating the opioid epidemic by facilitating timely identification and intervention in cases of fentanyl overdose or abuse. Market growth is primarily driven by the escalating prevalence of fentanyl-related fatalities and the increasing emphasis on proactive screening measures.

Market Growth Drivers:

The global Point of Care Fentanyl Test Kits Market is propelled by the growing incidence of fentanyl abuse and overdose cases worldwide. The rising availability of illicitly manufactured fentanyl, coupled with its potency and accessibility, has contributed to a surge in opioid-related deaths across demographic groups. As a result, there is a heightened demand for rapid and reliable point-of-care testing solutions capable of detecting fentanyl in various biological specimens, such as urine, saliva, and blood. Additionally, government initiatives aimed at expanding access to naloxone, an opioid overdose reversal agent, further underscore the importance of fentanyl testing in harm reduction strategies.

Market Restraints:

Despite the pressing need for fentanyl testing solutions, the Point of Care Fentanyl Test Kits Market faces challenges related to regulatory compliance, test accuracy, and cost-effectiveness. Ensuring the analytical sensitivity and specificity of rapid diagnostic tests for fentanyl presents technical hurdles for manufacturers, particularly in distinguishing fentanyl from structurally similar analogs and interfering substances. Moreover, variability in test performance across different sample matrices and environmental conditions necessitates ongoing validation and quality assurance measures to maintain diagnostic accuracy. Additionally, reimbursement limitations and the relatively high cost of point-of-care testing devices may impede market penetration, particularly in resource-constrained healthcare settings.

Market Opportunities:

The Point of Care Fentanyl Test Kits Market offers lucrative opportunities driven by advancements in immunoassay technologies, microfluidics, and biosensor platforms. Continued research and development efforts aimed at enhancing the sensitivity, specificity, and multiplexing capabilities of fentanyl test kits are expected to broaden their clinical utility and market acceptance. Furthermore, the integration of smartphone-based applications and cloud-based connectivity features into point-of-care testing devices enables remote data management, real-time surveillance, and epidemiological monitoring of fentanyl trends. Collaborative initiatives between industry stakeholders, public health agencies, and academic institutions are essential for driving innovation and addressing unmet needs in fentanyl testing and overdose prevention strategies.

Key Questions Answered in the Report:

  • What are the key factors driving the adoption of Point of Care Fentanyl Test Kits?
  • Which regions are expected to witness the highest demand for fentanyl testing solutions?
  • What are the prevailing regulatory and reimbursement considerations impacting the market landscape?
  • How are technological advancements influencing the development of next-generation fentanyl testing platforms?
  • Who are the leading players in the global Point of Care Fentanyl Test Kits Market, and what strategies are they employing to gain a competitive edge?

Competitive Intelligence and Business Strategy:

Leading players in the Point of Care Fentanyl Test Kits Market, such as, BTNX Inc., Canadian Research Chemicals Inc., The Bunk Police, DanceSafe, Microgenics Corporation, NarcCheck, Opioid Crisis Response Network (OCRN), SD Biosensor, Inc., Toronto Research Chemicals Inc., Wondfo, Carolina Liquid Chemistries Corp are focusing on product innovation, strategic partnerships, and geographic expansion to consolidate their market position. These companies are investing in research and development initiatives to enhance the performance characteristics and usability of fentanyl test kits, including faster turnaround times, simplified workflows, and improved detection limits. Collaborations with healthcare providers, addiction treatment centers, and law enforcement agencies enable market players to address diverse end-user needs and market segments effectively. Furthermore, efforts to streamline regulatory approvals, secure reimbursement coverage, and ensure compliance with quality standards are critical for sustaining long-term growth and market leadership in the evolving landscape.

Key Companies Profiled:

  • BTNX Inc.
  • Canadian Research Chemicals Inc.
  • The Bunk Police
  • DanceSafe
  • Microgenics Corporation
  • NarcCheck
  • Opioid Crisis Response Network (OCRN)
  • SD Biosensor, Inc.
  • Toronto Research Chemicals Inc.
  • Wondfo
  • Carolina Liquid Chemistries Corp

Point of Care Fentanyl Test Kits Market Research Segmentation:

By Application:

  • Drug of Abuse
  • Analgesic Application

By End-use:

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Cancer Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa
Product Code: PMRREP33839

Table of Contents

1. Executive Summary

  • 1.1. Global Point of Care Fentanyl Test Kits Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Application Lifecycle Analysis
  • 2.4. Point of Care Fentanyl Test Kits Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Point of Care Fentanyl Test Kits Market Outlook: Application
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.3.3.1. Drug of Abuse
      • 3.3.3.2. Analgesic Application
  • 3.4. Market Attractiveness Analysis: Application
  • 3.5. Global Point of Care Fentanyl Test Kits Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Hospitals
      • 3.5.3.2. Diagnostics Laboratories
      • 3.5.3.3. Forensic Laboratories
      • 3.5.3.4. Cancer Research Institutes
      • 3.5.3.5. Others
  • 3.6. Market Attractiveness Analysis: End User

4. Global Point of Care Fentanyl Test Kits Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Application
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.5.1. Drug of Abuse
    • 5.5.2. Analgesic Application
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Hospitals
    • 5.6.2. Diagnostics Laboratories
    • 5.6.3. Forensic Laboratories
  • 5.7. Market Attractiveness Analysis

6. Europe Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Application
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.5.1. Drug of Abuse
    • 6.5.2. Analgesic Application
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostics Laboratories
    • 6.6.3. Forensic Laboratories
    • 6.6.4. Cancer Research Institutes
    • 6.6.5. Others
  • 6.7. Market Attractiveness Analysis

7. East Asia Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Application
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.5.1. Drug of Abuse
    • 7.5.2. Analgesic Application
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostics Laboratories
    • 7.6.3. Forensic Laboratories
    • 7.6.4. Cancer Research Institutes
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Application
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.5.1. Drug of Abuse
    • 8.5.2. Analgesic Application
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostics Laboratories
    • 8.6.3. Forensic Laboratories
    • 8.6.4. Cancer Research Institutes
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. Latin America Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Application
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.5.1. Drug of Abuse
    • 9.5.2. Analgesic Application
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostics Laboratories
    • 9.6.3. Forensic Laboratories
    • 9.6.4. Cancer Research Institutes
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Point of Care Fentanyl Test Kits Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Application
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.5.1. Drug of Abuse
    • 10.5.2. Analgesic Application
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostics Laboratories
    • 10.6.3. Forensic Laboratories
    • 10.6.4. Cancer Research Institutes
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analgesic Application
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. BTNX Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Canadian Research Chemicals Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. The Bunk Police
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. DanceSafe
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Microgenics Corporation
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. NarcCheck
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Opioid Crisis Response Network (OCRN)
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. SD Biosensor, Inc.
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Toronto Research Chemicals Inc.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Wondfo
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Carolina Liquid Chemistries Corp.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!